Wilmington PharmaTech is a U.S.-based Contract Research Organization (CRO) specializing in custom synthesis and process research for the pharmaceutical and biotechnology industries. Founded in 2003, the company provides expertise in medicinal chemistry, process development, and manufacturing of intermediates and Active Pharmaceutical Ingredients (APIs) from milligram to kilogram scale. With a focus on speed, quality, and cost-effectiveness, Wilmington PharmaTech supports clients across all stages of drug discovery and development, helping advance innovative therapies to market.